1. Reader, J, van der Watt, ME, Taylor, D, Le Manach, C, Mittal, N, Ottilie, S et al.. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box. Nat Commun. 2021;12 (1):269. doi: 10.1038/s41467-020-20629-8. PubMed PMID:33431834 .
2. Fisher, GM, Cobbold, SA, Jezewski, A, Carpenter, EF, Arnold, M, Cowell, AN et al.. The Key Glycolytic Enzyme Phosphofructokinase Is Involved in Resistance to Antiplasmodial Glycosides. mBio. 2020;11 (6):. doi: 10.1128/mBio.02842-20. PubMed PMID:33293381 PubMed Central PMC7733947.
3. Vanaerschot, M, Murithi, JM, Pasaje, CFA, Ghidelli-Disse, S, Dwomoh, L, Bird, M et al.. Inhibition of Resistance-Refractory P. falciparum Kinase PKG Delivers Prophylactic, Blood Stage, and Transmission-Blocking Antiplasmodial Activity. Cell Chem Biol. 2020;27 (7):806-816.e8. doi: 10.1016/j.chembiol.2020.04.001. PubMed PMID:32359426 PubMed Central PMC7369637.
4. LaMonte, GM, Rocamora, F, Marapana, DS, Gnädig, NF, Ottilie, S, Luth, MR et al.. Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway. Nat Commun. 2020;11 (1):1780. doi: 10.1038/s41467-020-15440-4. PubMed PMID:32286267 PubMed Central PMC7156427.
5. Abraham, M, Gagaring, K, Martino, ML, Vanaerschot, M, Plouffe, DM, Calla, J et al.. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials. ACS Infect Dis. 2020;6 (4):613-628. doi: 10.1021/acsinfecdis.9b00482. PubMed PMID:32078764 PubMed Central PMC7155171.

Find us social!